D-0742-2026 Class II Ongoing
FDA drug recall D-0742-2026 was initiated by Bionpharma Inc. on June 26, 2026 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules The recall status is ongoing. Affected quantity: N/A.
Recall Details
- Product Type
- Drugs
- Report Date
- July 29, 2026
- Initiation Date
- June 26, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- N/A
Product Description
Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30.
Reason for Recall
Presence of Foreign Tablets/Capsules
Distribution Pattern
US Nationwide.
Code Information
Lot# 704C003, Exp. 12/31/2028